Clinical trials
Completed Phase 2 Central Nervous System Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
149 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 11 |
| 2001 | 9 |
| 2002 | 11 |
| 2003 | 8 |
| 2004 | 6 |
| 2005 | 8 |
| 2006 | 8 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 1 |
| 2011 | 4 |
| 2015 | 1 |
| 2017 | 7 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 149 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 13 |
| National Cancer Institute (NCI) | 12 |
| European Organisation for Research and Treatment of Cancer - EORTC | 11 |
| Memorial Sloan Kettering Cancer Center | 11 |
| Children's Oncology Group | 10 |
| Dana-Farber Cancer Institute | 7 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 7 |
| Radiation Therapy Oncology Group | 6 |
| Alliance for Clinical Trials in Oncology | 5 |
| Northwestern University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Neoplasms | 149 |
| Brain Neoplasms | 73 |
| Glioblastoma | 71 |
| Gliosarcoma | 65 |
| Astrocytoma | 59 |
| Glioma | 45 |
| Oligodendroglioma | 43 |
| Medulloblastoma | 26 |
| Ependymoma | 20 |
| Neuroblastoma | 16 |
Trials
Showing 1 to 25 of 149. Each trial links to its page on Pharma Observatory.
49 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.